Cyanocobalamin is primarily prescribed for vitamin B12 deficiency, which can occur due to a variety of conditions such as pernicious anemia, prolonged use of certain medications, surgery in the gastrointestinal tract or dietary deficiencies
AOD-9604 is a modified fragment of human growth hormone (specifically amino acids 177-191) designed to promote fat loss without the side effects of full growth hormone therapy
Long-term storage (months to years): Freeze the lyophilized vial at 80 C (112 F)
Phase 2 trial data (Jastreboff et al., NEJM 2023) demonstrated average weight reductions of approximately 1724% over 48 weeks notably higher than currently approved GLP-1 receptor agonists such as semaglutide, though direct comparisons are limited by differences in trial populations and designs
The contraindications relate to both the semaglutide and cyanocobalamin components, and careful consideration must be given to each ingredients specific safety profile and potential risks
Some research also suggests that if you become vitamin B12 deficient, it can increase your risk of age-related macular degeneration (AMD), which is a gradual type of vision loss common in people over 50